Flow cytometric immunophenotyping remains an indispensable tool for the diagnosis,
classification, staging, and monitoring of hematologic neoplasms. The last 10 years have …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy
derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course …

INTRODUCTION Dendritic cells (DCs) and monocytes consist of multiple specialized
subtypes that play a central role in pathogen sensing, phagocytosis, and antigen …

Most consensus leukemia & lymphoma antibody panels consist of lists of markers based on
expert opinions, but they have not been validated. Here we present the validated EuroFlow …

The objective of this study was to evaluate the clinical features, prognostic factors, and
efficacy of treatments in patients with blastic plasmacytoid dendritic cell neoplasm with a …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive and largely
incurable hematologic malignancy originating from plasmacytoid dendritic cells (pDCs) …

Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease
characterized by malignant proliferation of a contingent blastic plasmacytoid dendritic cell …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease of controversial
origin recently recognized as a neoplasm deriving from plasmacytoid dendritic cells (pDCs) …

Blastic plasmacytoid dendritic cell neoplasm is a rare clinicopathologic entity, characterized
by strong skin tropism and a poor prognosis. The diagnosis is generally made by skin biopsy …

The diagnosis of plasmacytoid dendritic cell leukaemia (pDCL) is based on the
immunophenotypic profile: CD4+ CD56+ lineageneg CD45RA+/ROneg CD11cneg …